רט-אויט ג'ל % 0.025 إسرائيل - العبرية - Ministry of Health

רט-אויט ג'ל % 0.025

cts chemical industries ltd, israel - tretinoin - ג'ל - tretinoin 0.025 %w/w - tretinoin - tretinoin - treatment of acne vulgaris.

אקנהמיצין פלוס إسرائيل - العبرية - Ministry of Health

אקנהמיצין פלוס

neopharm ltd - erythromycin; tretinoin - תמיסה - erythromycin 4 g / 100 g; tretinoin 0.025 g / 100 g - erythromycin, combinations - erythromycin, combinations - all forms of acne, both non-inflammatory forms with comedones and inflammatory forms with papules and pustules, particularly in the case of fat-rich skin.

פרוטופיק % 0.03 إسرائيل - العبرية - Ministry of Health

פרוטופיק % 0.03

dexcel ltd, israel - tacrolimus - משחה - tacrolimus 0.03 %w/w - tacrolimus - tacrolimus - treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies.maintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).

פרוטופיק % 0.1 إسرائيل - العبرية - Ministry of Health

פרוטופיק % 0.1

dexcel ltd, israel - tacrolimus - משחה - tacrolimus 0.1 %w/w - tacrolimus - tacrolimus - treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies.maintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).

זיילט إسرائيل - العبرية - Ministry of Health

זיילט

abic marketing ltd, israel - loteprednol etabonate; tobramycin - תרחיף לעין - tobramycin 3 mg/ml; loteprednol etabonate 5 mg/ml - tobramycin - tobramycin - zylet is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies.the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye.the particular anti-infect

לוטמקס תרחיף إسرائيل - العبرية - Ministry of Health

לוטמקס תרחיף

abic marketing ltd, israel - loteprednol etabonate - תרחיף לעין - loteprednol etabonate 5 mg / 1 ml - loteprednol - loteprednol - lotemax is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to otain an advisable diminution in edema and inflammation. lotemax is less effective than prednisolone acetate 1 % in two 28 day controlled clinical studies in acute anterior uveitis, where 72 % of patients treated with lotemax experienced resolution of anterior chamber cells, compared to 87 % of patients treated with prednisolone acetate 1 % . the incidence of patients with clinically significant increases in iop (> or = 10 mmhg) was 1 % with lotemax adn 6 % with prednisolone acetate 1 %. lotemax should not be used in patients who require a more potent corticosteroid for this indication. lotemax is also indicated for the treatment of po

קלובטאזול פרופיונאט - תרימה קרם إسرائيل - العبرية - Ministry of Health

קלובטאזול פרופיונאט - תרימה קרם

trima israel pharmaceutical products maabarot ltd - clobetasol propionate - קרם - clobetasol propionate 0.05 %w/w - clobetasol

אנסטילר إسرائيل - العبرية - Ministry of Health

אנסטילר

dexcel ltd, israel - betamethasone as dipropionate; calcipotriol as monohydrate - קצף לעור - betamethasone as dipropionate 0.5 mg / 1 g; calcipotriol as monohydrate 50 mcg / 1 g - calcipotriol, combinations

אנסטילר إسرائيل - العبرية - Ministry of Health

אנסטילר

dexcel ltd, israel - betamethasone as dipropionate; calcipotriol as monohydrate - קצף לעור - betamethasone as dipropionate 0.5 mg / 1 g; calcipotriol as monohydrate 50 mcg / 1 g - calcipotriol, combinations

בטאקלציפ טבע إسرائيل - العبرية - Ministry of Health

בטאקלציפ טבע

teva israel ltd - betamethasone as dipropionate; calcipotriol - משחה - calcipotriol 50 mcg / 1 g; betamethasone as dipropionate 0.5 mg / 1 g - calcipotriol, combinations